Prostate Cancer Clinical Trials in Detroit

Showing 161-180 of 355 trials

Genomics in Michigan Impacting Observation or Radiation

NCT02783950

To determine the impact of Decipher test results on adjuvant treatment decisions of high-risk post-RP patients with undetectable post-op prostate specific antigen (PSA) compared to clinical factors alone.

Prostate Cancer

University of Michigan Rogel Cancer Center356 participantsStarted Jan 2017

Ann Arbor, Michigan, United States • Detroit, Michigan, United States • Detroit, Michigan, United States +10 more locations

COMPLETEDPhase 2< 1 mile

Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)

NCT03473925

The purpose of this study is to assess the efficacy and safety of navarixin (MK-7123) in combination with pembrolizumab (MK-3475) in adults with one of three types of solid tumors: Programmed Death-Ligand 1 (PD-L1) positive refractory non-small cell lung cancer (NSCLC), castration resistant prostate cancer (CRPC) or microsatellite stable (MSS) colorectal cancer (CRC).

Solid TumorsNon-small Cell Lung CancerCastration Resistant Prostate Cancer+1 more

Merck Sharp & Dohme LLC107 participantsStarted Apr 2018

Scottsdale, Arizona, United States • Sarasota, Florida, United States • Baltimore, Maryland, United States +11 more locations

Genomics in Michigan Impacting Observation or Radiation

Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)

Prostate Cancer Trials in Other Cities

ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent

Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)

The Metformin Active Surveillance Trial (MAST) Study

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

Stockholm3 Validation Study in a Multi-Ethnic Cohort

Prostate Imaging Using MRI +/- Contrast Enhancement

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

COMbination of Bipolar Androgen Therapy and Nivolumab

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer

ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study

Other Conditions in Detroit